Compounding Pharmacies Market Growth and Analysis by 2028

Compounding Pharmacies Market Forecast to 2028 - Analysis By Product (Oral Medications, Topical Medications, Suppositories, Others); Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, Others) and Geography

Status : Published
Report Code : TIPRE00005407

Category : Life Sciences
No. of Pages : 149

Available Report Formats :

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Product ; Therapeutic Area and Geography

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are the driving factors for the compounding pharmacies market across the globe?

The factors that are driving growth of the market are drug shortage crisis across the globe, benefits associated with compounded medications and increasing adoption of customized medicine (Personalized medicine).

Who are the major players in the compounding pharmacies market?

The compounding pharmacies market majorly consists of the players such as Fagron, Inc., Elixir Compounding Pharmacy, Avella specialty pharmacy, B. Braun Melsungen AG, PharMEDium Healthcare Holdings, Inc., Fresenius Kabi AG, Belle SantÃ© Diagnostic & Therapeutic Institute Pvt. Ltd, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy and US Compounding Inc.

What is Compounding Pharmacies?

Compounding pharmacies or compound pharmacy role is to mix ingredients as per patients' needs and manufacture drugs that are not commercially available. Pharmacy compounding has been present since the beginning of time. It is essential in cases such as limited dosage strengths and dosage forms, drug allergies to certain ingredients, pediatrics, chemotherapy and veterinary medicine. Further, compounded medicines enhance pharmacist contribution to developing and implementing patient therapeutic plans and provide customized medications of high pharmaceutical quality. Additionally, as per law, compounding drugs does not include making copies of commercially available drug products. Compounding pharmacists can make flavored drugs in different dosage forms, such as liquids, topical creams, suppositories, transdermal gels, or other dosage forms suitable for patient's unique needs.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Compounding Pharmacies Market – By Product

1.3.2 Global Compounding Pharmacies Market – By Therapeutic Area

1.3.3 Global Compounding Pharmacies Market– By Geography

2. Compounding Pharmacies Market– Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Compounding Pharmacies Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Expert Opinion

5. Compounding Pharmacies Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Drug Shortage Crisis Across the World

5.1.2 Benefits of Compounded Medications

5.1.3 Increasing Adoption of Customized Medicine (Personalized Medicine)

5.2 Market Restraints

5.2.1 Product Recalls and Stringent Regulatory Requirements

5.3 Market Opportunities

5.3.1 Growing Demand for Compounding Pharmacy During COVID-19

5.4 Future Trends

5.4.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products

5.5 Impact Analysis

6. Compounding Pharmacies Market– Global Analysis

6.1 Global Compounding Pharmacies Market Revenue Forecast and Analysis

6.2 Global Compounding Pharmacies Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Compounding Pharmacies Market Analysis – By Product

7.1 Overview

7.2 Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

7.3 Oral Medications

7.3.1 Overview

7.3.2 Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Topical Medications

7.4.1 Overview

7.4.2 Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Suppositories

7.5.1 Overview

7.5.2 Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8. Compounding Pharmacies Market – By Therapeutic Area

8.1 Overview

8.2 Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

8.3 Pain Medications

8.3.1 Overview

8.3.2 Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Hormone Replacement Therapies

8.4.1 Overview

8.4.2 Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Dermatological Applications

8.5.1 Overview

8.5.2 Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9. Compounding Pharmacies Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028

9.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.1.1 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.2 North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.1.3 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4 US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4.1 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.4.2 US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.5 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.1 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.2 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.5.3 Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.6 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.1 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.2 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.6.3 Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028

9.2.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.1.1 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.1.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.2 Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.2.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.3.1 UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.3.2 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.3.3 UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.4 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.4.1.1 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.4.2 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.4.3 Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.4.4 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.5 France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.5.1 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.5.2 France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.6 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.6.1 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.6.2 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.6.3 Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.7 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.8 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.8.1 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.8.2 Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.2.9 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.10 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.2.10.1 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.2.10.2 Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.3 Asia Pacific: Compounding Pharmacies Market

9.3.1 Overview

9.3.2 Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)

9.3.3 Asia Pacific: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.4 Asia Pacific: Compounding Pharmacies Market, by Therapeutic Area – 2019–2028 (USD Million)

9.3.5 Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)

9.3.6 China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.1 China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.6.2 China: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.6.3 China: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.7 Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.1 Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.7.2 Japan: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.7.3 Japan: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.8 India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.1 India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.8.2 India: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.8.3 India: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.9 South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.1 South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.9.2 South Korea: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.9.3 South Korea: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.10 Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.1 Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.10.2 Australia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Million)

9.3.10.3 Australia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.3.11 Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.11.1 Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.3.11.2 Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.3.11.3 Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

9.4 East & Africa: Compounding Pharmacies Market

9.4.1 Overview

9.4.2 Middle East and Africa: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)

9.4.3 Middle East and Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.4 Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.5 Middle East and Africa: Compounding Pharmacies Market, by Country, 2020& 2028 (%)

9.4.6 UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.1 UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.6.2 UAE: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.6.3 UAE: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.7 Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1 Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.7.2 Saudi Arabia: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.7.3 Saudi Arabia: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.8 South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.8.1 South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.8.2 South Africa: Compounding Pharmacies Market, by Product, 2019–2028 (USD Millions)

9.4.8.3 South Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.4.9 Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.4.9.1 Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.4.9.2 Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.4.9.2.1 Rest of Middle East and Africa: Compounding Pharmacies Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028

9.5.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.1.1 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.1.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.2 South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.5.3 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.4 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.4.1 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.4.2 Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.5 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.6 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.6.1 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.6.2 Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.5.7 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.8 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.5.8.1 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.5.8.2 Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

10. Impact Of COVID-19 Pandemic on Global Compounding Pharmacies Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Rest of The World: Impact Assessment of COVID-19 Pandemic

11. Compounding Pharmacies Market– Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Fagron, Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Triangle Compounding Pharmacy

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 B.Braun Melsungen AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 PharMEDium Healthcare Holdings, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Fresenius Kabi AG

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Avella specialty pharmacy

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Vertisis Custom Pharmacy

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 US Compounding Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Elixir Compounding Pharmacy

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. A few drugs that are in short supply are listed below:

Table 2. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 4. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 5. US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 6. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 7. Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 8. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 9. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 10. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 11. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 12. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 13. UK Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 14. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 15. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 16. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. France Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 18. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 19. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 20. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 21. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 22. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 23. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 24. Asia Pacific Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 25. Asia Pacific Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 26. China Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 27. China Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 28. Japan Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 29. Japan Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 30. India Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 31. India Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 32. South Korea Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 33. South Korea Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 34. Australia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 35. Australia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 38. Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 39. Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 40. UAE Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 41. UAE Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 42. Saudi Arabia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 43. Saudi Arabia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 44. South Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Millions)

Table 45. South Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 46. Rest of Middle East and Africa Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 47. Rest of Middle East and Africa Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 48. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 49. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 50. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 51. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 52. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 53. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 54. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 55. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 56. Organic Developments Done By Companies

Table 57. Inorganic Developments Done By Companies

Table 58. Glossary of Terms, Compounding Pharmacies Market

LIST OF FIGURES

Figure 1. Compounding Pharmacies Market Segmentation

Figure 2. Compounding Pharmacies Segmentation, By Region

Figure 3. Global Compounding Pharmacies Market Overview

Figure 4. Oral Medications Held Largest Share of Product Segment in Compounding Pharmacies Market

Figure 5. North America to Show Remarkable Growth During Forecast Period

Figure 6. Compounding Pharmacies Market, by Geography (US$ Million)

Figure 7. Global Compounding Pharmacies Market– Leading Country Markets (US$ Million)

Figure 8. Global Compounding Pharmacies Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East & Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 15. Global Compounding Pharmacies Market– Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Compounding Pharmacies Market– By Geography Forecast and Analysis – 2020- 2028

Figure 17. Market Positioning of Key Players in Global Compounding Pharmacies Market

Figure 18. Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

Figure 19. Oral Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Topical Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Suppositories: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

Figure 24. Pain Medications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Hormone Replacement Therapies: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Dermatological Applications: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 29. North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 31. US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)

Figure 33. Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34. Europe Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 35. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36. Europe Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 37. UK Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38. Germany Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39. France Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. Italy Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Spain Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Rest of Europe Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 43. Asia Pacific: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)

Figure 44. Asia Pacific Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Million)

Figure 45. China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 46. Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 47. India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 48. South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. Middle East & Africa: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)

Figure 52. Middle East and Africa Compounding Pharmacies Market Revenue and Forecast to 2028 (USD Millions)

Figure 53. UAE: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 54. Saudi Arabia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. South Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. Rest of Middle East and Africa: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. South and Central America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 58. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 59. South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 60. Argentina Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 61. Brazil Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 62. Rest of South and Central America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 63. Impact of COVID-19 Pandemic in North American Country Markets

Figure 64. Impact of COVID-19 Pandemic in European Country Markets

Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 66. Impact Of COVID-19 Pandemic in Rest of The World Market

Figure 67. Growth Strategies Done by the Companies in the Market, (%)

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.